+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Armodafinil"

Armodafinil Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Armodafinil Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Armodafinil is a prescription medication used to treat mental disorders such as narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. It is a wakefulness-promoting agent that works by stimulating the central nervous system. Armodafinil is a derivative of modafinil, a drug that has been used to treat sleep disorders since the 1990s. Armodafinil is considered to be a more potent version of modafinil, with a longer duration of action. It is available in tablet form and is taken orally. Armodafinil is used to improve alertness and reduce fatigue in people with mental disorders. It is also used to improve cognitive performance in people with attention deficit hyperactivity disorder (ADHD). It is not approved for use in children. Armodafinil is a popular medication in the mental disorders drugs market. It is widely prescribed by doctors and is available in many countries. Some companies in the Armodafinil market include Cephalon, Mylan, Sun Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more